Single-dose intranasal adenovirus-based RSV vaccines targeting G and M2

Eunju Jang, Serin Lee, Jiyu Han, Jun Chang

Research output: Contribution to journalArticlepeer-review

Abstract

We have developed adenovector-based vaccines targeting G and M2 protein of respiratory syncytial virus. Single intranasal vaccination induced robust G protein-specific IgG and IgA responses, as well as M2-specific CD8+ T-cell immunity, and provided protection against RSV A and B infection. These findings suggest that this vaccine combination holds promising potential for effective RSV prevention.

Original languageEnglish
Article number139
Journalnpj Vaccines
Volume10
Issue number1
DOIs
StatePublished - Dec 2025

Bibliographical note

Publisher Copyright:
© The Author(s) 2025.

Fingerprint

Dive into the research topics of 'Single-dose intranasal adenovirus-based RSV vaccines targeting G and M2'. Together they form a unique fingerprint.

Cite this